Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gastrointestinal stromal tumor workshop.

J Berman1, T J O'Leary

  • 1Cancer Diagnosis Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Human Pathology
|June 30, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using individual lung ultrasonography at the group level to define treatment thresholds in large groups of calves for tailoring antimicrobial use: A simulation approach.

Preventive veterinary medicine·2026
Same author

Lung ultrasonography used as a diagnostic test for respiratory disease diagnosis in calves: systematic review and meta-analysis using a Bayesian latent-class modelling approach.

Journal of dairy science·2026
Same author

Preface to the special issue of <i>BMJ Military Health</i> on future soldier: delivering human advantage.

BMJ military health·2025
Same author

Self-reported hormonal contraceptive use in the British Armed Forces.

BMJ military health·2025
Same author

MSKI reduction strategies: evidence-based interventions to reduce musculoskeletal injuries in military service members.

BMJ military health·2024
Same author

Protein dose requirements to maximize skeletal muscle protein synthesis after repeated bouts of resistance exercise in young trained women.

Scandinavian journal of medicine & science in sports·2023

Gastrointestinal stromal tumors (GIST) show promising response to STI-571, a targeted therapy. Pathologists need standardized diagnostic criteria for effective GIST treatment and prognosis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gastroenterology

Background:

  • Gastrointestinal stromal tumor (GIST) is a neoplasm characterized by KIT receptor tyrosine kinase.
  • Conventional chemotherapy is often ineffective against GIST.
  • Targeted therapy offers a new avenue for GIST treatment.

Framework:

  • STI-571 (Gleevec) is a tyrosine kinase inhibitor targeting the KIT protein.
  • This agent represents a novel, non-cytotoxic approach to cancer therapy.
  • Early clinical trials and case reports demonstrate encouraging results for STI-571 in GIST.

Implementation:

  • STI-571 has shown efficacy in BCR-ABL-positive leukemias.
  • Early GIST clinical trials report significant positive outcomes.
  • Oncologists may soon prioritize STI-571 clinical trials for malignant GIST patients.

Related Experiment Videos

Implications:

  • Accurate GIST diagnosis and prognostic classification are crucial.
  • Pathologists require standardized methods for GIST diagnosis.
  • Understanding GIST biology is essential for guiding treatment decisions.